Mergers & Acquisitions - Anti-Arthritics/Rheumatics


Popular Filters

Mariel Therapeutics to acquire Stryker's BMP-7 assets

Mariel Therapeutics to acquire Stryker's BMP-7 assets


US clinical-stage drug developer Mariel Therapeutics has entered into a definitive agreement to acquire…

Anti-Arthritics/RheumaticsMariel TherapeuticsMergers & AcquisitionsNephrology and HepatologyPharmaceuticalStryker Corp

Savient to sell out to Crealta Pharma for around $120 million


US drugmaker Savient Pharmaceuticals, which recently elected to file voluntary bankruptcy protection…

Anti-Arthritics/RheumaticsCrealta PharmaceuticalsKrystexxaMergers & AcquisitionsPharmaceuticalSavient Pharmaceuticals

S&N launches new biologics firm, Bioventus, with focus on active orthopaedic healing


Bioventus, a new company providing active orthopaedic healing, launched yesterday following the finalization…

Anti-Arthritics/RheumaticsBiotechnologyBioventusMarkets & MarketingMergers & AcquisitionsSmith & Nephew

AstraZeneca to acquire Ardea Bio for $1.26 billion


In line with its stated policy of making strategic, rather than mega, acquisitions, Anglo-Swedish drug…

Anti-Arthritics/RheumaticsArdea BiosciencesAstraZenecaBiotechnologyGenito-urinarylesinuradMergers & AcquisitionsPharmaceutical

Kyowa Hakko sets up biosimilars joint venture with Fujifilm


Japanese digital camera and medical equipment conglomerate Fujifilm and drugmaker Kyowa Hakko Kirin have…

Anti-Arthritics/RheumaticsAsia-PacificBiotechnologyFujifilm Kyowa Kirin BiologicsGenericsHumiraKyowa Hakko KirinMergers & AcquisitionsResearch

Back to top